Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > EVO Evotec > Detailed Quotes

EVO Evotec

Watchlist
9.970
+0.040+0.40%
Close  02/07 16:00 ET
9.9700.0000.00%
Post Mkt Price 02/07 18:40 ET
High
10.075
Open
9.860
Turnover
129.87K
Low
9.780
Pre Close
9.930
Volume
13.19K
Market Cap
3.53B
P/E(TTM)
Loss
52wk High
16.460
Shares
353.91M
P/E(Static)
15.41
52wk Low
7.800
Float Cap
2.86B
Bid/Ask %
0.00%
Historical High
25.290
Shs Float
286.69M
Volume Ratio
0.79
Historical Low
7.800
Dividend TTM
--
Div Yield TTM
--
P/B
2.68
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.01%
Amplitude
2.97%
Avg Price
9.844
Lot Size
1
Float Cap
2.86B
Bid/Ask %
0.00%
Historical High
25.290
Shs Float
286.69M
Volume Ratio
0.79
Historical Low
7.800
Dividend TTM
--
P/B
2.68
Dividend LFY
--
Turnover Ratio
0.01%
Amplitude
2.97%
Avg Price
9.844
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties. The EVT Innovate develops drug discovery projects, assets and platforms, both internally or through academic collaborations. The company was founded by Manfred Eigen, Karsten Henco, Ulrich Aldag, Freimut Leidenberger, Heinrich Maria Schulte, Rudolf Rigler, and Charles Weissmann on December 8, 1993 and is headquartered in Hamburg, Germany.
CEO: Dr. Werner Lanthaler, PhD
Market: NASDAQ
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist